Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Receivables - Net (2024 - 2025)

Historic Receivables - Net for Nuvation Bio (NUVB) over the last 2 years, with Q3 2025 value amounting to $8.3 million.

  • Nuvation Bio's Receivables - Net rose 733125.0% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year increase of 733125.0%. This contributed to the annual value of $12.7 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Nuvation Bio reported Receivables - Net of $8.3 million as of Q3 2025, which was up 733125.0% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Receivables - Net registered a high of $12.7 million during Q4 2024, and its lowest value of $112000.0 during Q3 2024.